Role evidence
Usage summary
Strongest role: Secondary Or Exploratory
Inclusion-required count: 0
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
MSI-H / dMMR
ovarian cancer · Monoclonal Antibody
MSI-H / dMMR is flagged as cdx established context because public trials show secondary or exploratory evidence in 1 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 1
Common snippets: DMMR
Threshold label: Low
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: High
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT04870177